Application Nr Approved Date Route Status External Links
ANDA077873 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Paroxetine Extended-Release Tablets Are Indicated In Adults For The Treatment Of: • Major Depressive Disorder (Mdd) • Panic Disorder (Pd) • Social Anxiety Disorder (Sad) • Premenstrual Dysphoric Disorder (Pmdd) Paroxetine Extended-Release Tablets Are A Selective Serotonin Reuptake Inhibitor (Ssri) Indicated In Adults For The Treatment Of ( 1 ): • Major Depressive Disorder (Mdd) • Panic Disorder (Pd) • Social Anxiety Disorder (Sad) • Premenstrual Dysphoric Disorder (Pmdd)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Paroxetine Hydrochloride Hemihydrate PAROXETINE HYDROCHLORIDE HEMIHYDRATE ZINC527386

Comments